Search





Search





Markets
/
Stocks
/
gri
/

GRI Bio Inc

GRI

Add to Watchlist

1.390USD

-0.020-1.42%

Close 07-31 16:00（ET）Quotes delayed by 15 min

24.71KMarket Cap

LossP/E TTM

GRI Bio Inc

1.390

-0.020-1.42%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

GRI Cash Flow Statement

You can access the annual and quarterly cash flow statements of GRI Bio Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

FY2019Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-112.27%-3.69M

-48.62%-2.97M

-1.98%-2.31M

-47.87%-3.17M

21.20%-1.74M

64.05%-2.00M

-73.00%-2.27M

-71266.67%-2.14M

-280.48%-2.20M

-305.54%-5.56M

29.21%-1.31M

99.82%-3.00K

74.72%-579.00K

13.39%-1.37M

-43.68%-1.85M

34.91%-1.62M

22.32%-2.29M

-95.92%-1.58M

-21.15%-1.29M

---2.49M

---2.95M

-16.30%-808.00K

-20.36%-1.06M

---694.74K

---884.00K

Net income from continuing operations

34.41%-2.00M

-36.50%-2.66M

-58.29%-3.36M

-28.53%-2.89M

-61.42%-3.05M

2.79%-1.95M

0.70%-2.12M

65.38%-2.25M

12.23%-1.89M

-26.60%-2.00M

-106.87%-2.14M

-266.61%-6.50M

18.41%-2.15M

48.87%-1.58M

17.82%-1.03M

23.31%-1.77M

0.11%-2.63M

-110.76%-3.10M

-20.29%-1.26M

---2.31M

---2.64M

-68.56%-1.47M

-10.12%-1.04M

---871.49K

---949.00K

Operating gains losses

0.00%1.00K

-50.00%1.00K

0.00%1.00K

--1.00K

-99.41%1.00K

-88.89%2.00K

-94.74%1.00K

-100.00%0.00

789.47%169.00K

0.00%18.00K

5.56%19.00K

57.89%30.00K

5.56%19.00K

--18.00K

20.75%19.00K

--18.00K

--15.73K

--0.00

Other non-cash items

18.18%13.00K

0.00%12.00K

30.00%13.00K

108.45%12.00K

-8.33%11.00K

106.45%12.00K

131.25%10.00K

-106.67%-142.00K

-98.98%12.00K

-183.41%-186.00K

91.26%-32.00K

668.95%2.13M

7231.25%1.17M

1073.68%223.00K

-3427.27%-366.00K

3562.50%277.00K

131.37%16.00K

--19.00K

--11.00K

---8.00K

---51.00K

----

-100.00%0.00

--0.00

--137.00K

Change in working capital

-260.67%-1.73M

-288.12%-392.00K

392.27%567.00K

-253.99%-328.00K

394.54%1.08M

97.04%-101.00K

-136.53%-194.00K

-95.19%213.00K

-195.31%-366.00K

-2171.33%-3.41M

209.26%531.00K

7598.31%4.42M

197.67%384.00K

-111.74%-150.00K

-147.96%-486.00K

82.01%-59.00K

124.16%129.00K

111.94%1.28M

-120.22%-196.00K

---328.00K

---534.00K

289.87%603.00K

31.01%-89.00K

--154.67K

---129.00K

-Change in prepaid expenses

-46.43%105.00K

-55.56%-14.00K

375.00%132.00K

67.53%-63.00K

-65.25%196.00K

-103.11%-9.00K

44.19%-48.00K

71.80%-194.00K

1914.29%564.00K

502.08%289.00K

-119.28%-86.00K

-141.40%-688.00K

-28.21%28.00K

-69.62%48.00K

168.67%446.00K

-168.84%-285.00K

104.92%39.00K

186.81%158.00K

162.64%166.00K

--414.00K

---793.00K

-442.58%-182.00K

-86.62%-265.00K

--53.13K

---142.00K

Cash from non-recurring investing activities

Cash from operating activities

-112.27%-3.69M

-48.62%-2.97M

-1.98%-2.31M

-47.87%-3.17M

21.20%-1.74M

64.05%-2.00M

-73.00%-2.27M

-71266.67%-2.14M

-280.48%-2.20M

-305.54%-5.56M

29.21%-1.31M

99.82%-3.00K

74.72%-579.00K

13.39%-1.37M

-43.68%-1.85M

34.91%-1.62M

22.32%-2.29M

-95.92%-1.58M

-21.15%-1.29M

---2.49M

---2.95M

-16.30%-808.00K

-20.36%-1.06M

---694.74K

---884.00K

Investing cash flow

Net cash from continuing investing activities

----

--3.00K

----

--0.00

----

--0.00

--8.00K

----

--0.00

Capital expenditures

----

--3.00K

----

--0.00

----

--0.00

--8.00K

----

--0.00

Net cash flow from disposal of fixed assets

----

--3.00K

----

--0.00

----

--0.00

--8.00K

----

--0.00

Net cash flow from investment products

----

172.92%420.00K

140.78%1.33M

--876.00K

--1.15M

---576.00K

---3.27M

----

Cash from non-current investing activities

Net cash flow from investing activities

----

---3.00K

----

--0.00

----

-100.00%0.00

-100.91%-8.00K

----

172.92%420.00K

140.78%1.33M

--876.00K

--1.15M

---576.00K

---3.27M

--0.00

Financing cash flow

Cash flow from continuous financing activities

59227.27%6.50M

213.37%7.15M

88.50%1.25M

13.72%5.01M

-100.25%-11.00K

-41.21%2.28M

--661.00K

-36.35%4.40M

335.53%4.49M

--3.88M

-100.00%0.00

102.02%6.92M

4578.26%1.03M

100.00%0.00

247.62%31.00K

12328.57%3.42M

-100.15%-23.00K

-228.57%-23.00K

-90.91%-21.00K

---28.00K

--15.82M

75.02%-7.00K

-100.22%-11.00K

---28.02K

--4.98M

Net cash flow from debt Issuance/repayment

----

-100.00%0.00

--0.00

-100.00%0.00

--150.00K

-100.00%0.00

4882.61%1.10M

5534.78%1.25M

100.00%0.00

247.62%31.00K

17.86%-23.00K

-107.28%-23.00K

-228.57%-23.00K

-90.91%-21.00K

---28.00K

--316.00K

75.02%-7.00K

---11.00K

---28.02K

--0.00

Net cash flow from common stock issuance/repurchase

681900.00%6.82M

395.05%8.00M

57.64%1.62M

19.78%5.94M

-100.02%-1.00K

--1.62M

--1.03M

-46.47%4.96M

--5.50M

--0.00

168.81%9.27M

--0.00

--3.45M

-100.00%0.00

----

--0.00

--15.50M

-100.00%0.00

----

--1.00

--4.98M

Proceeds from stock option exercised by employees

----

-100.00%0.00

----

--761.00K

--1.00K

----

--0.00

--12.00K

----

Proceeds from issuance of warrants

----

--399.00K

----

Net cash flow from other financing activities

-3040.00%-314.00K

-787.50%-852.00K

-1.63%-373.00K

-67.68%-934.00K

99.01%-10.00K

-102.57%-96.00K

---367.00K

83.91%-557.00K

-360.91%-1.01M

--3.73M

--0.00

---3.46M

---220.00K

----

---399.00K

----

--0.00

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

59227.27%6.50M

213.37%7.15M

88.50%1.25M

13.72%5.01M

-100.25%-11.00K

-41.21%2.28M

--661.00K

-36.35%4.40M

335.53%4.49M

--3.88M

-100.00%0.00

102.02%6.92M

4578.26%1.03M

100.00%0.00

247.62%31.00K

12328.57%3.42M

-100.15%-23.00K

-228.57%-23.00K

-90.91%-21.00K

---28.00K

--15.82M

75.02%-7.00K

-100.22%-11.00K

---28.02K

--4.98M

Net cash flow

Beginning cash balance

63.66%8.23M

-14.56%4.05M

-19.38%5.12M

-19.80%3.28M

178.10%5.03M

36.07%4.75M

32.38%6.35M

294.16%4.09M

19988.89%1.81M

-26.29%3.49M

-8.08%4.80M

-182.85%-2.11M

-99.76%9.00K

-19.58%4.73M

-50.09%5.22M

-80.41%2.54M

3296.33%3.70M

536.80%5.88M

423.26%10.46M

--12.98M

--109.00K

-79.66%924.00K

346.21%2.00M

--4.54M

--448.00K

Current period cash flow changes

261.36%2.82M

1380.14%4.17M

33.60%-1.07M

-18.61%1.84M

-176.52%-1.75M

116.79%282.00K

-22.58%-1.61M

-67.25%2.26M

406.21%2.28M

-76.66%-1.68M

-168.10%-1.31M

157.88%6.91M

138.91%451.00K

56.42%-951.00K

89.31%-489.00K

206.27%2.68M

-109.00%-1.16M

-167.73%-2.18M

-325.67%-4.58M

---2.52M

--12.87M

-12.76%-815.00K

-126.25%-1.07M

---722.76K

--4.10M

Ending cash balance

236.73%11.05M

63.66%8.23M

-14.56%4.05M

-19.38%5.12M

-19.80%3.28M

178.10%5.03M

36.07%4.75M

32.38%6.35M

789.35%4.09M

-52.18%1.81M

-26.29%3.49M

-8.08%4.80M

-81.91%460.00K

2.13%3.78M

-19.58%4.73M

-50.09%5.22M

-80.41%2.54M

3296.33%3.70M

536.80%5.88M

--10.46M

--12.98M

-97.15%109.00K

-79.67%924.00K

--3.82M

--4.54M

Free cash flow

----

-48.77%-2.97M

----

64.05%-2.00M

-73.00%-2.27M

----

-305.54%-5.56M

29.21%-1.31M

99.32%-11.00K

----

13.39%-1.37M

-43.68%-1.85M

34.91%-1.62M

22.32%-2.29M

-95.92%-1.58M

-21.15%-1.29M

---2.49M

---2.95M

-16.30%-808.00K

-20.36%-1.06M

---694.74K

---884.00K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did GRI Bio Inc Generate?



GRI Bio Inc generated -10.19M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did GRI Bio Inc's Operating Cash Flow Change Year Over Year?



GRI Bio Inc's operating cash flow increased by -18.29% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does GRI Bio Inc Spend on Capital Expenditures?



GRI Bio Inc spent 3.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has GRI Bio Inc's Financing Cash Flow Changed?



GRI Bio Inc used 13.39M in financing activities in the latest quarter.

What is free cash flow and why does it matter for GRI?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was GRI Bio Inc’s free cash flow in the latest quarter?



Free cash flow was -10.19M reflecting a -18.33% change from the previous year.